(Press-News.org) A small study suggests women with multiple sclerosis have lower vitamin D levels during pregnancy and breastfeeding, according to a report posted online today that will appear in the March 2011 print issue of Archives of Neurology, one of the JAMA/Archives journals. However, these vitamin D levels were not associated with a greater risk of multiple sclerosis relapse after childbirth.
"During the last decade, low level of vitamin D, a potent immunomodulator, has emerged as an important risk factor for multiple sclerosis (MS) as well as other autoimmune diseases and certain cancers," the authors write as background information in the article. "The observation that healthy pregnant and lactating women are at particularly high risk of vitamin D insufficiency, regardless of race, suggests that pregnant and nursing mothers with MS may have a higher risk of relapses. However, it has already been well established that the risk of MS relapse decreases during pregnancy and increases in the postpartum period and that breastfeeding does not increase the risk of relapses."
Annette Langer-Gould, M.D., Ph.D., then of Stanford University School of Medicine, Stanford, Calif., and now of Kaiser Permanente Southern California's Department of Research and Evaluation, Pasadena, and colleagues studied 28 pregnant women with MS from Kaiser Permanente Northern California and the Stanford University outpatient neurology clinics. Participants donated blood and completed questionnaires at the beginning of the study, during their remaining trimesters of pregnancy and regularly during the first year after birth.
Of the 28 women, half (14) breastfed exclusively and 43 percent (12) relapsed within six months after giving birth. During pregnancy, average blood levels of 25-hydroxyvitamin (25[OH]D, a common measure of vitamin D) were 25.4 nanograms per milliliter, and were associated with the season. After birth, levels remained low among women who were exclusively breastfeeding. By four and six months after childbirth, 25(OH)D levels were an average of 5 nanograms per milliliter lower among women who breastfed exclusively than among women who did not.
However, these low postpartum vitamin D levels were not associated with risk of MS relapse. "If anything, by three to six months after childbirth, 25(OH)D levels were marginally higher among the women who relapsed within the first six months after childbirth compared with women who were relapse-free during the corresponding period," the authors write. "We do not believe that higher vitamin D levels increase the risk of postpartum relapses, as the rise we observed did not appear to occur prior to the onset of symptoms and the findings were of marginal statistical significance after accounting for season. Instead, we think this apparent inverse association is a reflection of the fact that most of the women who relapsed in the study also did not breastfeed or did so only briefly."
The findings imply that the recommended dose of vitamin D supplementation for women with MS during pregnancy and breastfeeding should be the same as for women who do not have MS, the authors conclude. "Our results suggest that future studies aimed at identifying and unraveling the relationship between vitamin D, pregnancy/lactation-related hormones and regulation of MS inflammation may reveal novel insights into MS pathophysiology," they write.
INFORMATION:
(Arch Neurol. Published online November 8, 2010. doi:10.1001/archneurol.2010.291) Available pre-embargo to the media at www.jamamedia.org.)
Editor's Note: This study was supported by grants form the National Institute of Neurological Disorders and Stroke of the National Institutes of Health and a Wadsworth Foundation Young Investigator's Award. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
To contact Annette Langer-Gould, M.D., Ph.D., call Socorro Serrano at 626-405-3004 or e-mail socorro.l.serrano@kp.org.
For more information, contact JAMA/Archives Media Relations at 312/464-JAMA (5262) or e-mail mediarelations@jama-archives.org.
Low vitamin D while pregnant or breastfeeding may not be associated with multiple sclerosis relapse
2010-11-09
ELSE PRESS RELEASES FROM THIS DATE:
Discovery could reveal secrets of ancient Martian and terrestrial atmospheres
2010-11-09
Chemists at UC San Diego have uncovered a new chemical reaction on tiny particulates in the atmosphere that could allow scientists to gain a glimpse from ancient rocks of what the atmospheres of the Earth and Mars were like hundreds of millions years ago.
Their discovery also provides a simple chemical explanation for the unusual carbonate inclusions found in a meteorite from Mars that was once thought by some scientists to be evidence of ancient Martian life.
"We never knew before how the atmosphere could be trapped in carbonate," said Mark Thiemens, dean of UC San ...
New research shows genetic test for lung cancer risk prompts smokers to quit
2010-11-09
Philadelphia – November 8, 2010 – New research shows a gene-based test for lung cancer risk assessment motivates smokers to quit or cut down, according to results of a clinical study presented today at the American Association of Cancer Research's Ninth Annual Conference on Frontiers in Cancer Prevention Research.
Six months after taking the Respiragene test to identify susceptibility for lung cancer risk, 32% of the randomly recruited smokers in the study had quit smoking altogether and a further 48% had reduced their intake of cigarettes. More than half of the smokers ...
Massachusetts Institute of Technology IDs new cancer drug target
2010-11-09
CAMBRIDGE, Mass. -- Suppressing cancer cells' ability to replicate damaged DNA could dramatically enhance the effectiveness of chemotherapy drugs such as cisplatin, according to a new pair of papers from MIT biologists.
In studies of mice, the researchers found that slowing down a specific system for tolerating DNA damage not only prolonged survival but also prevented relapsed tumors from becoming resistant to chemotherapy, and made tumors much less likely to spread to other parts of the body.
Two enzymes that play key roles in a cell's response to DNA damage could ...
Louisiana State University Health Sciences Center research shows fish oil component given up to 5 hours after stroke limits brain damage
2010-11-09
New Orleans, LA – Research led by Dr. Nicolas Bazan, Boyd Professor, Villere Chair, and Director of the Neuroscience Center of Excellence at LSU Health Sciences Center, has shown that Docosahexaenoic acid (DHA), a component of fish oil, is a powerful therapeutic agent that can protect brain tissue and promote recovery in an experimental model of acute ischemic stroke, even when treatment is delayed by up to five hours. These findings not only target a new stroke treatment approach, but also provide vital information about the length of the therapeutic window. The NIH-funded ...
Scientists make advance in dementia research
2010-11-09
The preservation of a protein found in particular synapses in the brain plays a key role in protecting against vascular dementia after a stroke, say researchers at King's College London.
The study, funded by the Dunhill Medical Trust, is published today in the 9 November issue of Neurology, the medical journal of the American Academy of Neurology. Researchers say the study findings increase understanding of vascular dementia, and highlight a possible target for future diagnoses and treatment of the condition.
Professor Paul Francis, King's College London, said: 'Vascular ...
Hebrew University-developed method for control of malaria applied in Africa
2010-11-09
Jerusalem, November 8, 2010 – Research carried out in Mali, West Africa, has demonstrated that a new, safe and uncomplicated insect control method, developed at the Hebrew University of Jerusalem, can bring about a serious decline in malaria-bearing mosquitoes in afflicted regions in the world.
The research in Africa was based on work carried out earlier in Israel by researchers at the Kuvin Center for the Study of Tropical and Infectious Diseases at the Hebrew University of Jerusalem that showed how attractants of plant origin (fruit or flowers) with a toxic sugar bait ...
Fat cells reach their limit and trigger changes linked to type 2 diabetes
2010-11-09
Scientists have found that the fat cells and tissues of morbidly obese people and animals can reach a limit in their ability to store fat appropriately. Beyond this limit several biological processes conspire to prevent further expansion of fat tissue and in the process may trigger other health problems.
Research funded by the Biotechnology and Biological Sciences Research Council (BBSRC), the Medical Research Council (MRC) and the European Union Sixth Framework Programme, shows that a protein called secreted frizzled-related protein 1 (SFRP1) is produced by fat cells ...
Researchers in Bonn find an 'altruism gene'
2010-11-09
Do you like to do good things for other people? If so, your genes might be responsible for this. At least, the results of a study conducted by researchers of the University of Bonn suggest this. According to the study, a minute change in a particular gene is associated with a significantly higher willingness to donate. People with this change gave twice as much money on average to a charitable cause as did other study subjects. The results have now been published in the journal Social Cognitive & Affective Neuroscience (doi: 10.1093/scan/nsq083).
The researchers working ...
Quantum memory for communication networks of the future
2010-11-09
Researchers from the Niels Bohr Institute at the University of Copenhagen have succeeded in storing quantum information using two 'entangled' light beams. Quantum memory or information storage is a necessary element of future quantum communication networks. The new findings are published in Nature Physics.
Quantum networks will be able to protect the security of information better than the current conventional communication networks. The cornerstone of quantum communication is a phenomenon called entanglement between two quantum systems, for example, two light beams. ...
Graphene gets a Teflon makeover
2010-11-09
Professor Andre Geim, who along with his colleague Professor Kostya Novoselov won the 2010 Nobel Prize for graphene – the world's thinnest material, has now modified it to make fluorographene – a one-molecule-thick material chemically similar to Teflon.
Fluorographene is fully-fluorinated graphene and is basically a two-dimensional version of Teflon, showing similar properties including chemical inertness and thermal stability.
The results are this week reported in the advanced online issue of the journal Small. The work is a large international effort and involved ...